Application of mouse normal lung organoid cytokine panel in lung organoid research

I. The Complex Structure of Lungs and the Need for Research Models

The mammalian lung is a sophisticated tree-like respiratory system primarily composed of airways and alveoli. This organ's complexity is reflected in its composition of over 50 known cell types distributed across various structures including airways, blood vessels, lymphatic vessels, connective tissue, nerves, and lung parenchyma. Epithelial cells, serving as the first line of defense directly exposed to inhaled air, are distributed along the proximal-distal axis of airways with multiple region-specific stem and progenitor cell populations, including basal cells and club cells in airways, bronchioalveolar stem cells (BASCs) at the bronchioalveolar duct junction, and alveolar type II epithelial cells (AT2) as the main stem cells in alveolar regions. When lungs are exposed to damaging factors such as air pollutants, cigarette smoke, bacteria, or viruses, repeated epithelial damage can trigger persistent inflammatory responses, potentially leading to chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), asthma, and other conditions. Therefore, establishing an in vitro model that accurately simulates human lung physiology and pathology is of great significance. In basic research, using mouse normal lung organoid cytokine kits can simulate the growth microenvironment of lung organoids, providing an important tool for studying the proliferation and differentiation mechanisms of lung stem cells.

II. The Concept and Technical Principles of Lung Organoids

Organoids are three-dimensional structures derived from stem cells that can simulate key structures, biological characteristics, and functions of their source organs in vitro. Lung organoids are primarily developed from induced pluripotent stem cells (iPSCs) or adult stem cells (ASCs), forming three-dimensional models containing alveolar and airway tissues. The core of their culture lies in simulating the in vivo stem cell microenvironment by adding specific cytokine combinations to regulate critical signaling pathways such as WNT, BMP, and FGF, maintaining stem cells' self-renewal and multipotent differentiation capabilities. In recent years, human stem cell-derived lung organoids have become powerful tools bridging translational research and clinical applications. The key factors included in mouse normal lung organoid cytokine kits can be used to optimize lung organoid culture conditions, supporting their long-term maintenance and functional studies in vitro.

III. Main Types of Adult Stem Cell-Derived Lung Organoids

Depending on their adult stem cell sources, lung organoids can be classified into several types. Airway basal cell-derived organoids, cultured in media containing epidermal growth factor (EGF), retinoic acid, and other components, can form organoids comprising basal cells, ciliated cells, and goblet cells, making them ideal screening tools. Airway secretory cell-derived organoids consist of club cells and goblet cells, providing a platform for studying secretory cell proliferation and differentiation mechanisms, and can be used to investigate molecular mechanisms of goblet cell metaplasia induced by cytokines such as interleukin-13 (IL-13) and interleukin-17A (IL-17A). Bronchioalveolar stem cell (BASC)-derived organoids, when co-cultured with lung endothelial or mesenchymal cells, can generate structurally complex bronchioalveolar-type lung organoids, simultaneously forming airway-like and alveolar regions, serving as powerful models for studying distal regeneration mechanisms after lung injury. Alveolar type II epithelial cell (AT2)-derived organoids, supported by mesenchymal cells, form spheres composed of AT2 cells and ducts composed of AT1 cells, widely used to study the regulation of AT2 to AT1 differentiation. The mouse normal lung organoid cytokine kit can provide optimized cytokine combinations for the culture of these various lung organoids, supporting their in vitro construction and maintenance.

IV. Technical Pathways and Applications of iPSC-Derived Lung Organoids

Induced pluripotent stem cell (iPSC) technology reprograms patient somatic cells back to an embryonic stem cell-like pluripotent state, providing a robust cell source for lung organoids. The differentiation of iPSCs into lung organoids is a multi-step process aimed at recapitulating embryonic lung development: first, iPSCs are induced into primitive endoderm using factors like Activin A; then, by regulating BMP, FGF, and WNT signaling, ventral foregut endoderm progenitor cells expressing NKX2.1 are formed; finally, under the action of cytokine combinations, they specialize into lung lineages and self-organize into three-dimensional organoids. iPSC-induced organoids have wide-ranging applications, including disease modeling, high-throughput drug screening, developmental biology research, and therapeutic exploration combined with gene editing technologies. In this process, key factors included in the mouse normal lung organoid cytokine kit can be used to optimize culture conditions for iPSC-directed differentiation into lung lineages, improving differentiation efficiency and organoid maturity.

V. Construction and Research Value of Lung Tumor Organoids

Lung tumor organoids are typically derived from fresh tumor tissues of patients and can highly simulate the histopathological features, gene expression profiles, and drug sensitivity of primary tumors. Compared to traditional cancer cell lines, tumor organoids have higher clinical fidelity, and their similarity to original tumor morphology can be confirmed through HE staining and immunohistochemical analysis. These organoids have been widely used in tumorigenesis mechanism research and drug screening, for example, to reveal the critical role of reactive oxygen species (ROS) in epithelial-mesenchymal transition (EMT) and tumor cell invasion and migration. Lung tumor organoids can also be compared with normal lung organoids to investigate tumor-specific changes and their molecular mechanisms. In drug screening, tumor organoids can be used to evaluate the sensitivity of different chemotherapeutic and targeted drugs, providing reference for personalized treatment plans.

VI. Application Prospects of Mouse Normal Lung Organoid Cytokine Kit

The mouse normal lung organoid cytokine kit has broad application prospects in lung organoid research. In infectious disease studies, lung organoids cultured with this kit can be used to simulate respiratory virus infection processes and investigate virus-host cell interaction mechanisms. In hereditary lung disease research, combining gene editing technology allows the introduction of specific mutations into normal lung organoids to construct disease models for mechanism exploration and drug screening. In drug toxicology assessment, the lung organoid culture system supported by this kit can be used to evaluate the pulmonary toxicity of inhaled drugs and environmental toxins.

VII. Which Manufacturers Provide Mouse Normal Lung Organoid Cytokine Kits?

Nanjing UA-BioTech Co., Ltd. has independently developed the "Lung Organoids Cytokine Set, Mouse", a high-performance cytokine kit specifically designed for constructing and maintaining mouse normal lung organoids. This kit employs an optimized cytokine combination to simulate the microenvironment signals of lung development and homeostasis maintenance, supporting long-term expansion and directed differentiation of mouse lung stem/progenitor cells. It provides standardized and reliable solutions for lung development research, disease model construction, and drug evaluation.

Nanjing UA-BioTech Co., Ltd. is always committed to providing cutting-edge, high-quality core reagents and tools for immunology, cell therapy, and innovative drug development. For detailed technical parameters, validation data, or specific application inquiries regarding the "Lung Organoids Cytokine Set, Mouse" (Catalog No.: UA090041), please feel free to contact us.